Tóm tắt
Đánh giá kết quả điều trị suy tim sau nhồi máu cơ tim bằng phương pháp cấy ghép tế bào gốc tủy xương tự thân
Trang chủ
NGHIÊN CỨU LÂM SÀNG
Số phát hành:
Đánh giá kết quả điều trị suy tim sau nhồi máu cơ tim bằng phương pháp cấy ghép tế bào gốc tủy xương tự thân
Nguyễn Lân Việt: Viện Tim mạch Việt Nam - Bệnh viện Bạch Mai;
Đỗ Doãn Lợi: Viện Tim mạch Việt Nam - Bệnh viện Bạch Mai;
Nguyễn Thị Bạch Yến: Viện Tim mạch Việt Nam - Bệnh viện Bạch Mai;
Phạm Mạnh Hùng: Viện Tim mạch Việt Nam - Bệnh viện Bạch Mai;
Nguyễn Quốc Anh: Bệnh viện Bạch Mai;
Lý Tuấn Khải: Bệnh viện Trung ương Quân đội 108;
Nguyễn Ngọc Quang: Viện Tim mạch Việt Nam - Bệnh viện Bạch Mai;
Phan Tuấn Đạt: Viện Tim mạch Việt Nam - Bệnh viện Bạch Mai;
Trần Bá Hiếu: Viện Tim mạch Việt Nam - Bệnh viện Bạch Mai;
Xuất bản: tháng 8 1, 2014
Views: 1
Tài liệu tham khảo
1.
1. Nguyễn Thị Bạch Yến, Trần Văn Đồng, Phạm Quốc Khánh và cộng sự (1996), “Tình hình bệnh mạch vành qua 130 trường hợp nằm viện tại Viện Tim mạch trong 5 năm (1/91 - 10/95)”, Tạp chí Tim mạch học Việt Nam, tr 1 - 5.
2.
2. Assmus B, et al (2007), “Transcoronary transplantation of functionally competent BMCs is associated with a decrease in natriuretic peptide serum levels and improved survival of patients with chronic postinfarction heart failure: Results of the TOPCARE-CHD registry”, Circulation, 1234.
3.
3. Beltrami AP, Urbanek K, Kajstura J, et al (2001), “Evidence that human cardiac myocytes divide after myocardial infarction”, N Engl J Med; 344:1750-7.
4.
4. Delewi R1, hirsch A, Tijssen Jg, et al (2014), “Impact of intracoronary bone marrow cell therapy on left ventricular function in the setting of ST-segment elevation myocardial infarction: a collaborative meta- analysis”, Eur Heart J; 35(15), 989-98
5.
5. huikuri hV1, Kervinen K, Niemelä M, et al (2008), “Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction”, Eur Heart J (22), 2723-32
6.
6. hirsch A, Nijveldt R, van der Vleuten PA, et al (2011), “Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled HEBE trial”, Eur Heart J; 32: 1736-1747
7.
7. Jassens S, et al (2006), “Autologous bone marrow -derived stem cells transfer in patient with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial”, Lancet , 113-121.
8.
8. Janssens S, Dubois C, Bogaert J, et al (2006), “Autologous bone marrow-derived stem-cell transfer in patients with ST- segment elevation myocardial infarction: double-blind, randomised controlled trial”, Lancet; 367: 113-121
9.
9. Latif A, etal (2007), “Adult bone marrow-derived cells for cardiac repair: asystematic review and meta-analysis”,
10.
Arch Intern Med , 989-97.
11.
10. Lunde K, et al (2007), “Exercise capacity and quality of life after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infaction: Results from the autologous stem cell translantation in acute myocardial infarction (ASTAMI) randomized controlled trial”, Am Heart J , (154), e1-8.
12.
11. Min JY, Sullivan MF, Yang Y, etal (2002), “Significant improvement of heart function bycotransplantation of human mesenchymal stem cells and fetal cardiomyocytes in postinfarcted pigs”, Ann Thorac Surg; 74:1568-75.
13.
12. Nguyen hL, ha DA, Phan DT, et al (2014), “Sex differences in clinical characteristics, hospital management practices, and in-hospital outcomes in patients hospitalized in a vietnamese hospital with a first acute myocardial infarction”, PloS One, 9 (4)
14.
13. Orlic D, Kajstura J, Chimenti S, et al (2001), “Bone marrow cells regenerate infarcted myocardium”,
15.
Nature; 410:701-5.
16.
14. Quyyumi AA, et al. (2011), “CD34+ cell infusion after ST-elevation myocardial infarction is associated with improved perfusion and is dose dependent”, American Heart Journal;161 (1):98-105.
17.
15. Rendon E, et al (2008), “Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review”, European Heart Journal , 1807-1818.
18.
16. Roncalli J, et al. (2011), “Intracoronary autologous mononucleated bone marrow cell infusion for acute myocardial infarction: results of the randomized multicenter BONAMI trial”, European Heart Journal;32(14):1748-57.
19.
17. Schachinger V, Assmus B, et al (2004), “Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI trial”, JACC, (44), 1690-1699.
20.
18. Schachinger V, et al (2006), “Improved clinical outcome after intracoronary administration of bone- marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial”, Eur Heart J, (27), 2775-83.
21.
19. Sheiban i, et al (2001), “Time course and determinants of left ventricular function recovery after primary angioplasty in patients with acute myocardial infarction”, J Am Coll Cardiol, (38), 464-71.
22.
20. Stamm C, Westphal B, Kleine hD, et al (2003), “Autologous bone-marrow stem-cell transplantation for myocardial regeneration”, Lancet; 361:45-46.
23.
21. Wolert KC, et al (2004), “Intracoronary autologous bonemarrow cell transfer after myocardial infarction: the BOOST trial”, Lancet, (364), 141-148.
24.
22. Yousef M, etal (2009), “The BALANCE Study: clinical benefit and long-term outcome after intracoronary autologous bone marrow cell transplantation in patients with acute myocardial infarction”, J Am Coll Cardiol, (53), 2262-2269.